Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection
Objective
To evaluate the efficacy of administration of a single 12-mL dose of canine parvovirus (CPV)-immune plasma for treatment of CPV enteritis.
Design
Prospective, randomized, double-blinded, placebo-controlled clinical trial.
Animals
14 dogs with naturally occurring CPV enteritis.
Procedures
Dogs were assigned to treatment groups on the basis of randomization tables and were administered a single IV dose of CPV-immune plasma (treatment group) or an equivalent volume of saline (0.9% NaCl) solution (placebo group) within 18 hours after admission to the hospital. Treatment and outcome variables evaluated included neutrophil, monocyte, and CPV counts; number of days of hospitalization; changes in body weight; and cost of treatment.
Results
When dogs treated with CPV-immune plasma were compared with dogs treated with saline solution, there were no significant differences detected among neutrophil or monocyte counts, magnitude of viremia, weight change, number of days of hospitalization, or cost of treatment.
Conclusions and Clinical Relevance
Administration of a single 12-mL dose of immune plasma soon after the onset of CPV enteritis in dogs was not effective in ameliorating clinical signs, reducing viremia, or hastening hematologic recovery.
Authors: Ryan F. Bragg, Amanda L. Duffy, Frank A. DeCecco, Donald K. Chung, Maura T. Green, Julia K. Veir, Steven W. Dow
Source: https://avmajournals.avma.org/
Comments
Related Articles
More news
Copyright © 2025 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment